Jasper Therapeutics Newsroom

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and Jasper Therapeutics (JSPR)

TipRanks20:33 ET

TD Cowen Remains a Buy on Jasper Therapeutics (JSPR)

TipRanksJul 10 07:19 ET

Jasper Therapeutics Analyst Ratings

BenzingaJul 8 06:52 ET

Jasper Therapeutics Analyst Ratings

BenzingaJun 27 05:57 ET

Jasper Therapeutics Analyst Ratings

BenzingaJun 18 09:53 ET

Buy Rating for Jasper Therapeutics Amid Promising Briquilimab Trials and Asthma Market Potential

TipRanksMay 20 14:30 ET

Jasper Therapeutics Analyst Ratings

BenzingaMay 20 11:58 ET

Jasper Therapeutics Analyst Ratings

BenzingaMay 15 11:24 ET

RBC Capital Sticks to Their Buy Rating for Jasper Therapeutics (JSPR)

TipRanksMay 15 06:35 ET

Analysts Are Bullish on Top Healthcare Stocks: Stereotaxis (STXS), Jasper Therapeutics (JSPR)

TipRanksMay 14 11:10 ET

Analysts Offer Insights on Healthcare Companies: Adicet Bio (ACET), Jasper Therapeutics (JSPR) and Lucid Diagnostics (LUCD)

TipRanksMay 13 11:55 ET

Jasper Therapeutics Analyst Ratings

BenzingaMay 6 06:40 ET

Buy Rating Affirmed: Jasper Therapeutics' Briquilimab Shows Promising Outlook in Chronic Urticaria Treatment Market

TipRanksApr 24 23:01 ET

Jasper Therapeutics Analyst Ratings

BenzingaApr 3 07:34 ET

Jasper Therapeutics Analyst Ratings

BenzingaMar 28 04:37 ET

Buy Rating Affirmed for Jasper Therapeutics as Briquilimab Shows Market Potential in Chronic Urticaria Treatment

TipRanksMar 20 09:10 ET

Analysts' Top Healthcare Picks: Jasper Therapeutics (JSPR), Alphatec Holdings (ATEC)

TipRanksMar 20 09:06 ET

Jasper Therapeutics Analyst Ratings

BenzingaMar 18 08:34 ET

Buy Rating for Jasper Therapeutics: Promising Prospects for Briquilimab in Treating Chronic Urticaria

TipRanksMar 18 05:50 ET

Jasper Therapeutics Analyst Ratings

BenzingaMar 7 08:04 ET